跳至主要内容
临床试验/NCT01886625
NCT01886625撤回不适用

Single-port Thoracoscopic Sympathicotomy for Treatment of Complex Regional Pain Syndrome Type I, a Feasibility Study.

University of Groningen2 个研究点 分布在 1 个国家开始时间: 2015年8月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
2
主要终点
Change in perceived pain measured in Visual Analogue Scale

研究概览

简要总结

Background of the study: CRPS type-1 is a pain syndrome that usually develops after an initiating noxious event (e.g. fracture) in an extremity. Although treatment options life dimethyl-sulphoxide (DMSO), N-acetylcysteine (NAC) and intensive physical therapy exist, the treatment effect is often unsatisfactory, even leading to amputation of the extremity. Surgical treatment of chronic pain disorders by dividing the sympathetic chain is an established treatment. Its more invasive nature has prevented widespread application. After introduction of minimal invasive techniques in recent years, the UMCG has now devised a truly minimal invasive, yet safe and effective thoracoscopic technique, that requires only a single 1 cm long incision in the anterior axillary line. This technique is developed as treatment for primary focal axillary and palmar hyperhidrosis, and is performed in over 50 patients producing very satisfying results. This fact has led to the hypothesis that this same surgical technique can offer this group of chronic pain patients a safe, effective treatment modality.

Objective of the study: The effect of the intervention on pain an regain of function in de affected extremity. This will be quantified in multiple questionnaires at baseline and three follow-up points, and by clinical evaluation of the hand function at baseline and two follow-up points.

Study design: Single center prospective feasibility study

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 - 65 years.
  • CRPS-1 defined according to IASP-Bruehl criteria at the wrist or lower arm level.
  • Continuing pain which is disproportionate to any inciting event
  • Must report at least one symptom in each of the four following categories
  • Sensory: reports of hyperesthesia
  • Vasomotor: reports of temperature asymmetry, skin color change or asymmetry.
  • Sudomotor/edema: reports of edema, sweating changes, sweating asymmetry
  • Motor/trophic: reports of decreased range of motion, motor dysfunction (weakness, tremor, dystonia), trophic changes (hair, nail, skin)
  • Must display at least one sign in two or more of the following categories:
  • Sensory: evidence of hyperalgesia (to pinprick) and/or allodynia (to light touch)
  • Vasomotor: evidence of temperature asymmetry, color changes, asymmetry
  • Sudomotor/edema: evidence of edema, sweating changes, sweating asymmetry
  • Motor/trophic: evidence of decreased range of motion, motor dysfunction (weakness, tremor, dystonia), trophic changes (hair, nail, skin)

排除标准

  • Known COPD > Gold class
  • History of smoking > 20 pack years, due to higher risk of complications following unilateral lung- deflation and re-insufflation.
  • Documented substance addiction.
  • Previous intra-thoracic pleural drainage on affected side.
  • Previous thoracic surgery on affected side (including sternotomy). - Gross pulmonary or pleural abnormalities on chest X-ray.
  • Pregnancy, determined by preoperative pregnancy test.
  • Unsuitable anatomy (e.g. due to severe physical malformations).

结局指标

主要结局

Change in perceived pain measured in Visual Analogue Scale

时间窗: Baseline, 1, 3 and 6 months postoperative

次要结局

  • Change in function in extremity(Baseline, 1 and 6 months after intervention)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michiel Kuijpers

Principal Investigator

University of Groningen

研究点 (2)

Loading locations...

相似试验